165 related articles for article (PubMed ID: 31883832)
1. CD22 and CD72 contribute to the development of scleroderma in a murine model.
Zhao C; Matsushita T; Ha Nguyen VT; Tennichi M; Fujimoto M; Takehara K; Hamaguchi Y
J Dermatol Sci; 2020 Jan; 97(1):66-76. PubMed ID: 31883832
[TBL] [Abstract][Full Text] [Related]
2. CD22 and CD72 cooperatively contribute to the development of the reverse Arthus reaction model.
Nguyen VTH; Matsushita T; Zhao C; Fujimoto M; Takehara K; Tedder TF; Hamaguchi Y
J Dermatol Sci; 2019 Jul; 95(1):36-43. PubMed ID: 31262443
[TBL] [Abstract][Full Text] [Related]
3. A role for FcγRIIB in the development of murine bleomycin-induced fibrosis.
Sawada K; Hamaguchi Y; Mizumaki K; Oishi K; Maeda S; Ikawa Y; Komuro A; Takehara K; Matsushita T
J Dermatol Sci; 2021 Dec; 104(3):201-209. PubMed ID: 34844843
[TBL] [Abstract][Full Text] [Related]
4. The Fibrosis and Immunological Features of Hypochlorous Acid Induced Mouse Model of Systemic Sclerosis.
Meng M; Tan J; Chen W; Du Q; Xie B; Wang N; Zhu H; Wang K
Front Immunol; 2019; 10():1861. PubMed ID: 31481954
[TBL] [Abstract][Full Text] [Related]
5. B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.
Asano N; Fujimoto M; Yazawa N; Shirasawa S; Hasegawa M; Okochi H; Tamaki K; Tedder TF; Sato S
Am J Pathol; 2004 Aug; 165(2):641-50. PubMed ID: 15277237
[TBL] [Abstract][Full Text] [Related]
6. Modulation of B cell regulatory molecules CD22 and CD72 in myasthenia gravis and multiple sclerosis.
Lu J; Li J; Zhu TQ; Zhang L; Wang Y; Tian FF; Yang H
Inflammation; 2013 Jun; 36(3):521-8. PubMed ID: 23184497
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of percentage of lymphocytes B with expression of co-receptors CD 40, CD22 and CD72 in hypertrophied adenoid at children with otitis media with effusion].
Wysocka J; Zelazowska-Rutkowska B; Ratomski K; Skotnicka B; Hassmann-Poznańska E
Otolaryngol Pol; 2009; 63(6):504-8. PubMed ID: 20198985
[TBL] [Abstract][Full Text] [Related]
8. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
[TBL] [Abstract][Full Text] [Related]
9. Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin.
Ohashi T; Yamamoto T
Exp Dermatol; 2015 Sep; 24(9):698-702. PubMed ID: 25959255
[TBL] [Abstract][Full Text] [Related]
10. The Role of TLR7 and TLR9 in the Pathogenesis of Systemic Sclerosis.
Wang C; Oishi K; Kobayashi T; Fujii K; Horii M; Fushida N; Kitano T; Maeda S; Ikawa Y; Komuro A; Hamaguchi Y; Matsushita T
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892317
[TBL] [Abstract][Full Text] [Related]
11. Potential roles of interleukin-17A in the development of skin fibrosis in mice.
Okamoto Y; Hasegawa M; Matsushita T; Hamaguchi Y; Huu DL; Iwakura Y; Fujimoto M; Takehara K
Arthritis Rheum; 2012 Nov; 64(11):3726-35. PubMed ID: 22833167
[TBL] [Abstract][Full Text] [Related]
12. Myeloid cell populations and fibrogenic parameters in bleomycin- and HOCl-induced fibrosis.
Raker VK; Ook KY; Haub J; Lorenz N; Schmidt T; Stegemann A; Böhm M; Schuppan D; Steinbrink K
Exp Dermatol; 2016 Nov; 25(11):887-894. PubMed ID: 27307019
[TBL] [Abstract][Full Text] [Related]
13. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A
Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317
[TBL] [Abstract][Full Text] [Related]
14. BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance.
Matsushita T; Kobayashi T; Mizumaki K; Kano M; Sawada T; Tennichi M; Okamura A; Hamaguchi Y; Iwakura Y; Hasegawa M; Fujimoto M; Takehara K
Sci Adv; 2018 Jul; 4(7):eaas9944. PubMed ID: 30009261
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis.
Takahashi T; Asano Y; Ichimura Y; Toyama T; Taniguchi T; Noda S; Akamata K; Tada Y; Sugaya M; Kadono T; Sato S
Arthritis Rheumatol; 2015 Jan; 67(1):254-65. PubMed ID: 25302613
[TBL] [Abstract][Full Text] [Related]
16. A modified murine model of systemic sclerosis: bleomycin given by pump infusion induced skin and pulmonary inflammation and fibrosis.
Liang M; Lv J; Zou L; Yang W; Xiong Y; Chen X; Guan M; He R; Zou H
Lab Invest; 2015 Mar; 95(3):342-50. PubMed ID: 25502178
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulating role of the JAKs inhibitor tofacitinib in a mouse model of bleomycin-induced scleroderma.
Aung WW; Wang C; Xibei J; Horii M; Mizumaki K; Kano M; Okamura A; Kobayashi T; Matsushita T
J Dermatol Sci; 2021 Mar; 101(3):174-184. PubMed ID: 33451905
[TBL] [Abstract][Full Text] [Related]
18. Suppressive Regulation by MFG-E8 of Latent Transforming Growth Factor β-Induced Fibrosis via Binding to αv Integrin: Significance in the Pathogenesis of Fibrosis in Systemic Sclerosis.
Fujiwara C; Uehara A; Sekiguchi A; Uchiyama A; Yamazaki S; Ogino S; Yokoyama Y; Torii R; Hosoi M; Suto C; Tsunekawa K; Murakami M; Ishikawa O; Motegi SI
Arthritis Rheumatol; 2019 Feb; 71(2):302-314. PubMed ID: 30175895
[TBL] [Abstract][Full Text] [Related]
19. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
Pamuk ON; Can G; Ayvaz S; Karaca T; Pamuk GE; Demirtas S; Tsokos GC
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
[TBL] [Abstract][Full Text] [Related]
20. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
